skip to content

Roche enters partnership with Alnylam to co-develop and co-commercialise RNAi therapeutic zilebesiran to treat hypertension in patients with high cardiovascular risk

Investors

Investor updates
view all

stay updated

get the latest news and updates to your inbox.